News

News
Partner news

Persephone Biosciences Inc. Announces Collaboration with Janssen Biotech, Inc.

Read full story
JNJ Press releases

LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER RESULTS

Read full story
JNJ Press releases

New report reveals strength of the UK’s thriving genomics sector

Read full story
JNJ Press releases

MESTAG THERAPEUTICS EXTENDS SEED FINANCING TO $45 MILLION AND WELCOMES NEW INVESTORS FORBION, GV (FORMERLY GOOGLE VENTURES) AND NORTHPOND VENTURES

Read full story
Partner news

BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase

Read full story
Partner news

ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration

Read full story
Partner news

World-leading genomics project to give insights into health and disease - In a major advance for public health, a £200m project involving the government, charity and four leading pharmaceutical companies was announced today

Read full story
Partner news

BIO-Europe® Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

Read full story
Partner news

Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding

Read full story
Partner news

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

Read full story
Partner news

Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Read full story
JNJ Press releases

Johnson & Johnson Innovation announces winners of the Singapore QuickFire Challenge in collaboration with ETPL and SMART

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches Seoul Innovation QuickFire Challenge in Collaboration with Seoul Metropolitan Government and KHIDI

Read full story
Partner news

TRACON Pharmaceuticals Announces a Strategic Licensing Collaboration for Two Janssen Oncology Assets and a $5 Million Equity Investment from Johnson & Johnson Innovation – JJDC, Inc.

Read full story
Partner news

Asceneuron Raises CHF 30 Million in a Series A Financing

Read full story